TrialSignal
Clinical trial intelligence report
Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT03290274-Jul 28, 2026
NCT ID
NCT03290274
Status
UNKNOWN
Phase
NA
Sponsor
Hospital San Carlos, Madrid
Executive brief
Investment-Ready Snapshot
Clinical Trial to Evaluate the Efficacy and Security of Deep Brain Stimulation in Alzheimer´s Disease is a NA clinical asset sponsored by Hospital San Carlos, Madrid in Alzheimer Disease. SEO and diligence focus: Deep brain stimulation (fornix), Deep brain stimulation (Basal nucleus of Meynert), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT03290274
Indication
Alzheimer Disease
Modality
medical device
Target
Deep brain stimulation (fornix), Deep brain stimulation (Basal nucleus of Meynert)
Intervention
Deep brain stimulation (fornix), Deep brain stimulation (Basal nucleus of Meynert)
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.